Fluor Corporation experienced a challenging third quarter in 2025, reporting a GAAP net loss of $697 million, largely driven by a $653 million charge related to the Santos ruling and a $401 million reduction in NuScale's share price. Despite these significant impacts, the company achieved $3.3 billion in new awards, with 99% being reimbursable, and reported a strong adjusted EPS of $0.68, up 33% year-over-year. The company also generated $286 million in operating cash flow and increased its full-year guidance for adjusted EPS and EBITDA.
Fluor reported a GAAP net loss of $697 million, primarily due to a $653 million charge for the Santos ruling and a $401 million reduction in NuScale's share price.
New awards totaled $3.3 billion, a 21% increase year-over-year, with 99% being reimbursable projects.
Adjusted EPS increased by 33% year-over-year to $0.68, and adjusted EBITDA rose by 29% to $161 million.
The company's backlog stood at $28.2 billion, with 82% attributable to reimbursable projects, and cash and marketable securities improved to $2.8 billion.
Fluor has increased its full-year 2025 guidance for adjusted EBITDA and adjusted EPS, reflecting confidence in its operational performance despite market uncertainties. The company also anticipates full monetization of its NuScale investment by the end of Q2 2026.